ASCEND BY NTHRYS
Research Abroad Products

Genomics Project Topics

Browse all focused areas across all project categories under this field.

Showing 2029–2040 of 2250 project topics
Pulmonary Hypertension Genetic Risk Assessment and Precision Medicine Tool
A cloud-based diagnostic platform that screens for pathogenic variants in PH-related genes including BMPR2, CAV1, and ESMR2 to stratify patients by genetic subtype and treatment responsiveness. The tool monetizes through tiered subscription models for hospitals, high-volume genetic testing revenue sharing, and pharmaceutical partnerships for biomarker-driven clinical trials.
Genomics of Rare Lung Diseases Click to view more details →
Bronchiectasis Genetic Basis Identification and Clinical Decision Support
A comprehensive genomic analysis platform that identifies monogenic causes of non-cystic fibrosis bronchiectasis including immunodeficiency and ciliary dysfunction genes to inform targeted therapeutic strategies. Revenue is generated through clinical workflow integration fees, insurance billing codes optimization, and exclusive data licensing agreements with respiratory disease research consortia.
Genomics of Rare Lung Diseases Click to view more details →
Lupus Nephritis Renal Transcriptome Profiling
Analyzing kidney biopsy RNA-seq from lupus nephritis patients for identifying molecular classes associated with treatment response.
Genomics of Connective Tissue Diseases Click to view more details →
Systemic Sclerosis Blood Gene Expression Genomics
Profiling peripheral blood RNA-seq in SSc patients for identifying fibrotic, inflammatory, and proliferative gene expression subsets.
Genomics of Connective Tissue Diseases Click to view more details →
Sjögren Syndrome Minor Salivary Gland Genomics
Characterizing single cell transcriptome of minor salivary gland infiltrates in Sjögren syndrome for understanding immunopathogenesis.
Genomics of Connective Tissue Diseases Click to view more details →
Dermatomyositis Skin and Muscle Transcriptomics
Profiling skin biopsy and muscle RNA-seq in dermatomyositis for identifying disease-specific gene expression signatures by autoantibody subtype.
Genomics of Connective Tissue Diseases Click to view more details →
Ehlers-Danlos Syndrome Collagen Mutation Detection Platform
A commercial genomic sequencing and variant analysis SaaS platform that identifies pathogenic collagen gene mutations across EDS subtypes for rapid diagnostic confirmation. This enables clinics and genetic testing labs to monetize EDS patient screening with 48-hour turnaround reports and premium interpretation services.
Genomics of Connective Tissue Diseases Click to view more details →
Marfan Syndrome FBN1 Gene Variant Classification Tool
A proprietary bioinformatics tool that curates and classifies FBN1 variants using machine learning trained on clinical outcomes and structural protein modeling data. The platform generates revenue through per-sample analysis fees charged to diagnostic labs and provides risk stratification data licensing to pharmaceutical companies developing targeted therapies.
Genomics of Connective Tissue Diseases Click to view more details →
Familial Hypercholesterolemia Genetic Risk Stratification Engine
A cloud-based genomic risk assessment tool that analyzes LDLR, APOB, and PCSK9 variants to predict cardiovascular outcomes and therapy response in FH patients. The commercial model combines diagnostic test fees with enterprise licensing to insurers and pharmaceutical companies for patient stratification in precision medicine programs.
Genomics of Connective Tissue Diseases Click to view more details →
Osteogenesis Imperfecta COL1A Phenotype Prediction Software
An AI-powered genomic interpretation platform that links COL1A1/COL1A2 mutations to OI severity classification and fracture risk prediction for personalized clinical management. Revenue is generated through subscription licensing to orthopedic centers, pediatric bone disease clinics, and life insurance underwriting services requiring genetic risk assessment.
Genomics of Connective Tissue Diseases Click to view more details →
Ankylosing Spondylitis HLA-B27 and ERAP Genomic Screening Service
A comprehensive genomic screening service that combines HLA-B27 typing with ERAP1/ERAP2 variant analysis to predict AS susceptibility and biologic therapy response in inflammatory arthritis patients. The service model generates revenue through laboratory testing fees, predictive biomarker licensing to rheumatology practices, and partnerships with biologic manufacturers for patient selection programs.
Genomics of Connective Tissue Diseases Click to view more details →
Mixed Connective Tissue Disease Autoimmune Gene Expression Biomarker Panel
A commercial RNA-sequencing biomarker panel that quantifies disease-specific transcriptomic signatures from patient blood samples to enable early MCTD diagnosis and disease activity monitoring. The business model combines diagnostic test revenue with tiered pricing for rheumatologists and institutional licensing agreements with hospital systems for integrated electronic health records reporting.
Genomics of Connective Tissue Diseases Click to view more details →